• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塞内加尔南部布恩基林地区 pfk13 和 pfmdr1 多态性的流行情况。

Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal.

机构信息

Laboratory of Bacteriology and Virology, Hospital Aristide Le Dantec, Dakar, Senegal.

Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF), Dakar, Senegal.

出版信息

PLoS One. 2021 Mar 26;16(3):e0249357. doi: 10.1371/journal.pone.0249357. eCollection 2021.

DOI:10.1371/journal.pone.0249357
PMID:33770151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7996989/
Abstract

BACKGROUND

Delayed Plasmodium falciparum parasite clearance has been associated with Single Nucleotide Polymorphisms (SNPs) in the kelch protein propeller domain (coded by pfk13 gene). SNPs in the Plasmodium falciparum multidrug resistance gene 1 (pfmdr1) are associated with multi-drug resistance including the combination artemether-lumefantrine. To our knowledge, this is the first work providing information on the prevalence of k13-propeller and pfmdr1 mutations from Sédhiou, a region in the south of Senegal.

METHODS

147 dried blood spots on filter papers were collected from symptomatic patients attending a hospital located in Bounkiling City, Sédhiou Region, Southern Senegal. All samples were collected between 2015-2017 during the malaria transmission season. Specific regions of the gene pfk13 and pfmdr1 were analyzed using PCR amplification and Sanger sequencing.

RESULTS

The majority of parasites (92.9%) harboured the pfk13 wild type sequence and 6 samples harboured synonymous changes. Regarding pfmdr1, wild-type alleles represented the majority except at codon 184. Overall, prevalence of 86Y was 11.9%, 184F was 56.3% and 1246Y was 1.5%. The mutant allele 184F decreased from 73.7% in 2015 to 40.7% in 2017. The prevalence of haplotype NFD decreased from 71.4% in 2015 to 20.8% in 2017.

CONCLUSIONS

This study provides the first description of pfk13 and pfmdr1 genes variations in Bounkiling, a city in the Sédhiou Region of Senegal, contributing to closing the gap of information on anti-malaria drug resistance molecular markers in southern Senegal.

摘要

背景

疟原虫清除延迟与kelch 蛋白螺旋桨结构域中的单核苷酸多态性(SNP)有关(由 pfk13 基因编码)。疟原虫多药耐药基因 1(pfmdr1)中的 SNP 与多药耐药有关,包括青蒿琥酯-咯萘啶联合用药。据我们所知,这是首次从塞内加尔南部的塞迪奥地区的布恩基林市医院就诊的有症状患者中提供有关 k13-螺旋桨和 pfmdr1 突变流行率的信息。

方法

2015-2017 年疟疾传播季节,在塞内加尔南部塞迪奥地区布恩基林市的一家医院,采集了 147 个滤纸干血斑。所有样本均来自就诊的有症状患者。使用 PCR 扩增和 Sanger 测序分析 pfk13 和 pfmdr1 基因的特定区域。

结果

大多数寄生虫(92.9%)携带 pfk13 野生型序列,有 6 个样本携带同义突变。关于 pfmdr1,野生型等位基因占多数,除了 184 密码子。总的来说,86Y 的流行率为 11.9%,184F 为 56.3%,1246Y 为 1.5%。突变等位基因 184F 从 2015 年的 73.7%下降到 2017 年的 40.7%。NFD 单倍型的流行率从 2015 年的 71.4%下降到 2017 年的 20.8%。

结论

本研究首次描述了塞内加尔塞迪奥地区布恩基林市 pfk13 和 pfmdr1 基因的变异情况,有助于填补塞内加尔南部抗疟药物耐药分子标记信息的空白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9a/7996989/42a0071ffa44/pone.0249357.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9a/7996989/0634e3342073/pone.0249357.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9a/7996989/42a0071ffa44/pone.0249357.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9a/7996989/0634e3342073/pone.0249357.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b9a/7996989/42a0071ffa44/pone.0249357.g002.jpg

相似文献

1
Prevalence of pfk13 and pfmdr1 polymorphisms in Bounkiling, Southern Senegal.塞内加尔南部布恩基林地区 pfk13 和 pfmdr1 多态性的流行情况。
PLoS One. 2021 Mar 26;16(3):e0249357. doi: 10.1371/journal.pone.0249357. eCollection 2021.
2
Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.肯尼亚基苏木县尼亚永地区与不同抗疟药物耐药性相关的疟原虫基因突变流行情况。
Infect Genet Evol. 2020 Mar;78:104121. doi: 10.1016/j.meegid.2019.104121. Epub 2019 Nov 19.
3
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.2015 年安哥拉三省无并发症恶性疟原虫感染患者中青蒿素和咯萘啶耐药相关分子标志物的流行情况。
Malar J. 2018 Feb 20;17(1):84. doi: 10.1186/s12936-018-2233-5.
4
Molecular surveillance of anti-malarial resistance pfcrt, pfmdr1, and pfk13 polymorphisms in African Plasmodium falciparum imported parasites to Wuhan, China.对输入性非洲恶性疟原虫 pfcrt、pfmdr1 和 pfk13 多态性的抗疟耐药性进行分子监测。
Malar J. 2021 May 1;20(1):209. doi: 10.1186/s12936-021-03737-8.
5
Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.贵州省从非洲输入的恶性疟原虫分离株中 pfcrt、pfmdr1 和 K13-推进器基因的多态性。
BMC Infect Dis. 2020 Jul 16;20(1):513. doi: 10.1186/s12879-020-05228-8.
6
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania.青蒿琥酯-咯萘啶治疗无并发症疟疾的疗效和安全性以及在坦桑尼亚大陆使用青蒿素为基础的联合疗法十年后 Pfk13 和 Pfmdr1 多态性的流行情况。
Malar J. 2019 Mar 21;18(1):88. doi: 10.1186/s12936-019-2730-1.
7
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.坦桑尼亚蒿甲醚-本芴醇相关恶性疟原虫多药耐药蛋白1基因多态性监测
Malar J. 2014 Jul 9;13:264. doi: 10.1186/1475-2875-13-264.
8
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.缅甸恶性疟原虫疟疾中K13突变和pfmdr1拷贝数变异
Malar J. 2016 Feb 24;15:110. doi: 10.1186/s12936-016-1147-3.
9
Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.斯威士兰疟原虫分离株中的抗疟药物耐药标志物:天然寄生虫分离株中 pfmdr1-86F 的鉴定。
Malar J. 2010 Mar 3;9:68. doi: 10.1186/1475-2875-9-68.
10
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.评估肯尼亚西部参加抗疟药物疗效研究的儿童中的抗疟药物耐药性分子标志物。
Malar J. 2020 Aug 14;19(1):291. doi: 10.1186/s12936-020-03358-7.

引用本文的文献

1
The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis.青蒿素类药物治疗的疟疾患者中 Pfk13 多态性的流行情况:系统评价和荟萃分析。
Parasitol Res. 2024 May 14;123(5):209. doi: 10.1007/s00436-024-08203-3.
2
Ex vivo RSA and pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.2017 年塞内加尔的体外 RSA 和 pfkelch13 靶向扩增子深度测序显示寄生虫对青蒿素的敏感性。
Malar J. 2023 May 26;22(1):167. doi: 10.1186/s12936-023-04588-1.
3
Ex vivo RSA and Pfkelch13 targeted-amplicon deep sequencing reveal parasites susceptibility to artemisinin in Senegal, 2017.

本文引用的文献

1
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.基于青蒿素的联合疗法的疗效和安全性,以及 Pfkelch13 和 Pfcoronin 分子标志物在塞内加尔治疗失败中的意义。
Sci Rep. 2020 Jun 1;10(1):8907. doi: 10.1038/s41598-020-65553-5.
2
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.青蒿琥酯-阿莫地喹和青蒿琥酯-氨酚喹啉治疗后预防疟疾的持续时间以及 pfmdr1 86Y 和 pfcrt 76T 的影响:个体患者数据的荟萃分析。
BMC Med. 2020 Feb 25;18(1):47. doi: 10.1186/s12916-020-1494-3.
3
2017年塞内加尔的体外环孢子蛋白抗原变异分析(RSA)和恶性疟原虫Kelch13靶向扩增子深度测序揭示了疟原虫对青蒿素的敏感性。
Res Sq. 2023 Feb 6:rs.3.rs-2538775. doi: 10.21203/rs.3.rs-2538775/v1.
4
Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.青蒿琥酯-阿莫地喹和青蒿琥酯-甲氟喹用于治疗利比里亚无并发症恶性疟原虫疟疾:体内疗效和分子标志物的频率。
Malar J. 2022 Apr 27;21(1):134. doi: 10.1186/s12936-022-04140-7.
5
Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across Cameroon.在喀麦隆的疟疾传播媒介中,对青蒿素和联合用药耐药性的分子驱动因素进行异种监测。
Gene. 2022 May 5;821:146339. doi: 10.1016/j.gene.2022.146339. Epub 2022 Feb 17.
6
Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum.青蒿素耐药性在非洲疟原虫分离株中潜在中介的流行情况。
Malar J. 2021 Dec 2;20(1):451. doi: 10.1186/s12936-021-03987-6.
Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria.
青蒿琥酯-咯萘啶联合疗法治疗失败:尼日利亚贝宁城三例报告。
Rev Soc Bras Med Trop. 2019 Oct 10;52:e20190163. doi: 10.1590/0037-8682-0163-2019. eCollection 2019.
4
Plasmodium falciparum Kelch Propeller Polymorphisms in Clinical Isolates from Ghana from 2007 to 2016.2007 年至 2016 年加纳临床分离株中的疟原虫 Kelch 螺旋桨多态性。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00802-19. Print 2019 Nov.
5
Proof of concept: used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014-2017.概念验证:2014 年至 2017 年期间,在几内亚比绍比绍,使用疟疾快速诊断检测进行平行测序,以监测抗疟药物耐药性的分子标记。
Malar J. 2019 Jul 26;18(1):252. doi: 10.1186/s12936-019-2894-8.
6
Modulation of in vitro antimalarial responses by polymorphisms in Plasmodium falciparum ABC transporters (pfmdr1 and pfmdr5).疟原虫 ABC 转运蛋白(pfmdr1 和 pfmdr5)多态性对体外抗疟反应的调节。
Acta Trop. 2019 Aug;196:126-134. doi: 10.1016/j.actatropica.2019.05.020. Epub 2019 May 17.
7
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.疟疾病原体人群中 K13-螺旋桨基因多态性:流行情况和危险因素的系统评价
Malar J. 2019 Mar 7;18(1):60. doi: 10.1186/s12936-019-2701-6.
8
Changing Molecular Markers of Antimalarial Drug Sensitivity across Uganda.乌干达抗疟药物敏感性的分子标志物变化。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.01818-18. Print 2019 Mar.
9
Emerging implications of policies on malaria treatment: genetic changes in the gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa.疟疾治疗政策的新影响:非洲影响对蒿甲醚-本芴醇和青蒿琥酯-阿莫地喹敏感性的基因中的遗传变化。
BMJ Glob Health. 2018 Oct 19;3(5):e000999. doi: 10.1136/bmjgh-2018-000999. eCollection 2018.
10
Selective sweeps and genetic lineages of Plasmodium falciparum multi-drug resistance (pfmdr1) gene in Kenya.肯尼亚恶性疟原虫多药耐药(pfmdr1)基因的选择清除和遗传谱系。
Malar J. 2018 Oct 30;17(1):398. doi: 10.1186/s12936-018-2534-8.